+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Embolotherapy Market - Global Forecast 2026-2032- Product Image
Embolotherapy Market - Global Forecast 2026-2032- Product Image
New

Embolotherapy Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 196 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 4829978
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The embolotherapy market is evolving rapidly as healthcare systems worldwide shift toward minimally invasive procedures. Senior decision-makers require a clear view of new clinical demands, technology capabilities, and operational requirements to ensure continued competitiveness in this dynamic environment.

Market Snapshot: Embolotherapy Market Growth and Outlook

The global embolotherapy market grew from USD 5.22 billion in 2025 to USD 5.68 billion in 2026, with a projected compound annual growth rate (CAGR) of 9.19% and a forecasted market value of USD 9.67 billion by 2032. This notable trajectory highlights expanding clinical adoption for both vascular and oncologic procedures, leveraged by constant innovations in device design. These advancements enable safer, more efficient interventions, prompting organizations to respond to strong clinical demand. Device manufacturers, in turn, are accelerating the development of advanced solutions for procedure complexity, safety, and efficiency across a growing spectrum of cases.

Scope & Segmentation of the Embolotherapy Market

This embolotherapy market report delivers carefully segmented insights tailored to the needs of senior leaders across healthcare, medical technology, and procurement. Stakeholders gain a structured understanding of key market divisions and evolving operational trends, supporting targeted decision-making and strategy development.

  • Device Types: Balloons, coils, liquid embolics, particle embolics, and plugs—each distinguished by unique material attributes and procedural suitability for specific clinical scenarios.
  • Procedural Applications: Neurovascular embolization targets conditions such as arteriovenous malformations and aneurysms; tumor embolization addresses oncologic needs; peripheral, prostate artery, and uterine fibroid embolization meet diverse procedural demands, with additional applications in transarterial chemoembolization and radioembolization.
  • End-User Settings: Ambulatory surgical centers, hospitals, as well as specialty oncology and vascular clinics, each confronted by distinctive workflow, resource, and operational challenges.
  • Regional Markets: Americas, Europe, Middle East & Africa, and Asia-Pacific regions, each defined by local regulatory standards, healthcare infrastructure, and commercial landscapes.
  • Technological Innovations: Improvements in materials, microcatheter engineering, integrated imaging support, and devices designed for easier handling and efficient supply chain management are advancing procedural capabilities and standardization.

In-depth segmentation allows both manufacturers and providers to calibrate product design, procurement, and market entry strategies to match clinical environments and regional variations, fostering more precise and effective business operations.

Key Takeaways: Strategic Insights for Decision-Makers

  • Minimally invasive embolotherapy’s expanding role is supported by improved device performance and maturing clinical outcomes, strengthening its place in integrated patient care pathways.
  • Procurement now balances device efficacy with the product lifecycle and places increased weight on cost-effectiveness and operational reliability within the purchasing process.
  • The range of applications is broadening, with new device platforms enabling earlier-stage interventions or combined protocols, which drives investment in clinician education and adaptable device design.
  • Streamlined inventory processes and faster device turnover further aid operational efficiency, supporting standardization in care delivery across major hospital systems and specialized clinics.
  • Diverse infrastructure and policy environments require flexible supply chain and commercialization models to secure access and mitigate risks resulting from regional disparities.
  • Market participants include established multinational enterprises and emerging regional innovators, each pursuing distinct strategies through tailored service offerings, partnership initiatives, and product enhancements focused on client needs.

Tariff Impact: Procurement and Supply Chain Strategies

Recent tariff revisions have increased cost pressures at multiple stages of the embolotherapy device supply chain. Procurement leaders are responding by diversifying supplier relationships, favoring longer-term agreements to address volatility, and emphasizing regional manufacturing where feasible. Manufacturers are validating new material sources and certifying alternative suppliers, while shifting towards pricing models and bundled procurement packages aimed at controlling overall spending. Rigorous compliance processes, including comprehensive documentation, underpin these efforts to ensure continuity and reduce the risk of device supply disruptions.

Methodology & Data Sources

The report applies a robust mixed-methods research approach, combining direct interviews with clinical and procurement leaders and observation of actual embolotherapy procedures. Systematic secondary research across peer-reviewed literature, regulatory filings, supplier documents, and tender records supports comprehensive market validation. Rigorous triangulation and peer review ensure actionable insights for strategic decision-makers.

Why This Report Matters

  • Offers actionable guidance for aligning procurement strategies, clinician education, and investment planning with the evolving needs of modern care delivery.
  • Enables responsive adaptation to shifting policy and supply chain trends that affect commercialization and operational agility in global markets.
  • Provides recommendations to accelerate safe technology adoption, manage operational risks, and support enduring market competitiveness.

Conclusion

Senior leaders can leverage the insights and recommendations presented in this report to drive informed adoption and sustainable growth within the embolotherapy market. Data-driven strategies support confident, future-oriented decisions across clinical and operational functions.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Embolotherapy Market, by Product Type
8.1. Balloons
8.2. Coils
8.3. Liquid Embolics
8.4. Particle Embolics
8.5. Plugs
9. Embolotherapy Market, by Application
9.1. Neurovascular Embolization
9.1.1. Arteriovenous Malformation
9.1.2. Cerebral Aneurysm
9.1.3. Tumor Embolization
9.2. Peripheral Embolization
9.2.1. Peripheral Arterial Embolization
9.2.2. Peripheral Venous Embolization
9.3. Prostate Artery Embolization
9.4. Transarterial Chemoembolization
9.5. Transarterial Radioembolization
9.6. Uterine Fibroid Embolization
10. Embolotherapy Market, by End User
10.1. Ambulatory Surgical Centers
10.2. Hospitals
10.3. Specialty Clinics
10.3.1. Oncology Centers
10.3.2. Vascular Centers
11. Embolotherapy Market, by Region
11.1. Americas
11.1.1. North America
11.1.2. Latin America
11.2. Europe, Middle East & Africa
11.2.1. Europe
11.2.2. Middle East
11.2.3. Africa
11.3. Asia-Pacific
12. Embolotherapy Market, by Group
12.1. ASEAN
12.2. GCC
12.3. European Union
12.4. BRICS
12.5. G7
12.6. NATO
13. Embolotherapy Market, by Country
13.1. United States
13.2. Canada
13.3. Mexico
13.4. Brazil
13.5. United Kingdom
13.6. Germany
13.7. France
13.8. Russia
13.9. Italy
13.10. Spain
13.11. China
13.12. India
13.13. Japan
13.14. Australia
13.15. South Korea
14. United States Embolotherapy Market
15. China Embolotherapy Market
16. Competitive Landscape
16.1. Market Concentration Analysis, 2025
16.1.1. Concentration Ratio (CR)
16.1.2. Herfindahl Hirschman Index (HHI)
16.2. Recent Developments & Impact Analysis, 2025
16.3. Product Portfolio Analysis, 2025
16.4. Benchmarking Analysis, 2025
16.5. Abbott Laboratories
16.6. Artio Medical Inc.
16.7. B. Braun Melsungen AG
16.8. Balt Extrusion SA
16.9. Boston Scientific Corporation
16.10. Cardinal Health Inc.
16.11. Cook Medical LLC
16.12. Embolx Inc.
16.13. EndoShape Inc.
16.14. Guerbet SA
16.15. Instylla Inc.
16.16. Johnson & Johnson
16.17. Kaneka Corporation
16.18. Medtronic plc
16.19. Medtronic plc
16.20. Merit Medical Systems Inc.
16.21. Penumbra Inc.
16.22. QT Vascular Ltd.
16.23. Shape Memory Medical Inc.
16.24. Sirtex Medical Limited
16.25. Stryker Corporation
16.26. Surefire Medical Inc.
16.27. Terumo Corporation
16.28. TriSalus Life Sciences Inc.
16.29. Vascular Solutions Inc.
List of Figures
FIGURE 1. GLOBAL EMBOLOTHERAPY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL EMBOLOTHERAPY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL EMBOLOTHERAPY MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. UNITED STATES EMBOLOTHERAPY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 11. CHINA EMBOLOTHERAPY MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL EMBOLOTHERAPY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY BALLOONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY BALLOONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY BALLOONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY COILS, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY COILS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY COILS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY LIQUID EMBOLICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY LIQUID EMBOLICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY LIQUID EMBOLICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PARTICLE EMBOLICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PARTICLE EMBOLICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PARTICLE EMBOLICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PLUGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PLUGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PLUGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY ARTERIOVENOUS MALFORMATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY ARTERIOVENOUS MALFORMATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY ARTERIOVENOUS MALFORMATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY CEREBRAL ANEURYSM, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY CEREBRAL ANEURYSM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY CEREBRAL ANEURYSM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY TUMOR EMBOLIZATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY TUMOR EMBOLIZATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY TUMOR EMBOLIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL ARTERIAL EMBOLIZATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL ARTERIAL EMBOLIZATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL ARTERIAL EMBOLIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL VENOUS EMBOLIZATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL VENOUS EMBOLIZATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL VENOUS EMBOLIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PROSTATE ARTERY EMBOLIZATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PROSTATE ARTERY EMBOLIZATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PROSTATE ARTERY EMBOLIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY TRANSARTERIAL CHEMOEMBOLIZATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY TRANSARTERIAL CHEMOEMBOLIZATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY TRANSARTERIAL CHEMOEMBOLIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY TRANSARTERIAL RADIOEMBOLIZATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY TRANSARTERIAL RADIOEMBOLIZATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY TRANSARTERIAL RADIOEMBOLIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY UTERINE FIBROID EMBOLIZATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY UTERINE FIBROID EMBOLIZATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY UTERINE FIBROID EMBOLIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY ONCOLOGY CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY ONCOLOGY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY ONCOLOGY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY VASCULAR CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY VASCULAR CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY VASCULAR CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 73. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 74. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 75. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2032 (USD MILLION)
TABLE 76. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2032 (USD MILLION)
TABLE 77. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 78. AMERICAS EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 79. NORTH AMERICA EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. NORTH AMERICA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 81. NORTH AMERICA EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 82. NORTH AMERICA EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2032 (USD MILLION)
TABLE 83. NORTH AMERICA EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2032 (USD MILLION)
TABLE 84. NORTH AMERICA EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 85. NORTH AMERICA EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 86. LATIN AMERICA EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. LATIN AMERICA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 88. LATIN AMERICA EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 89. LATIN AMERICA EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2032 (USD MILLION)
TABLE 90. LATIN AMERICA EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2032 (USD MILLION)
TABLE 91. LATIN AMERICA EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 92. LATIN AMERICA EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2032 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2032 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 100. EUROPE EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. EUROPE EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 102. EUROPE EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 103. EUROPE EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2032 (USD MILLION)
TABLE 104. EUROPE EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2032 (USD MILLION)
TABLE 105. EUROPE EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 106. EUROPE EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 107. MIDDLE EAST EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. MIDDLE EAST EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 109. MIDDLE EAST EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 110. MIDDLE EAST EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2032 (USD MILLION)
TABLE 111. MIDDLE EAST EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2032 (USD MILLION)
TABLE 112. MIDDLE EAST EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 113. MIDDLE EAST EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 114. AFRICA EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. AFRICA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 116. AFRICA EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 117. AFRICA EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2032 (USD MILLION)
TABLE 118. AFRICA EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2032 (USD MILLION)
TABLE 119. AFRICA EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 120. AFRICA EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 121. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 123. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 124. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2032 (USD MILLION)
TABLE 125. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2032 (USD MILLION)
TABLE 126. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 127. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 129. ASEAN EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. ASEAN EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 131. ASEAN EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 132. ASEAN EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2032 (USD MILLION)
TABLE 133. ASEAN EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2032 (USD MILLION)
TABLE 134. ASEAN EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 135. ASEAN EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 136. GCC EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 137. GCC EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 138. GCC EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 139. GCC EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2032 (USD MILLION)
TABLE 140. GCC EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2032 (USD MILLION)
TABLE 141. GCC EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 142. GCC EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 143. EUROPEAN UNION EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. EUROPEAN UNION EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 145. EUROPEAN UNION EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 146. EUROPEAN UNION EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2032 (USD MILLION)
TABLE 147. EUROPEAN UNION EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2032 (USD MILLION)
TABLE 148. EUROPEAN UNION EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 149. EUROPEAN UNION EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 150. BRICS EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 151. BRICS EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 152. BRICS EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 153. BRICS EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2032 (USD MILLION)
TABLE 154. BRICS EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2032 (USD MILLION)
TABLE 155. BRICS EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 156. BRICS EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 157. G7 EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 158. G7 EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 159. G7 EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 160. G7 EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2032 (USD MILLION)
TABLE 161. G7 EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2032 (USD MILLION)
TABLE 162. G7 EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 163. G7 EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 164. NATO EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 165. NATO EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 166. NATO EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 167. NATO EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2032 (USD MILLION)
TABLE 168. NATO EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2032 (USD MILLION)
TABLE 169. NATO EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 170. NATO EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 171. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 172. UNITED STATES EMBOLOTHERAPY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 173. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 174. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 175. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2032 (USD MILLION)
TABLE 176. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2032 (USD MILLION)
TABLE 177. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 178. UNITED STATES EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 179. CHINA EMBOLOTHERAPY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 180. CHINA EMBOLOTHERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 181. CHINA EMBOLOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 182. CHINA EMBOLOTHERAPY MARKET SIZE, BY NEUROVASCULAR EMBOLIZATION, 2018-2032 (USD MILLION)
TABLE 183. CHINA EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL EMBOLIZATION, 2018-2032 (USD MILLION)
TABLE 184. CHINA EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 185. CHINA EMBOLOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Embolotherapy market report include:
  • Abbott Laboratories
  • Artio Medical Inc.
  • B. Braun Melsungen AG
  • Balt Extrusion SA
  • Boston Scientific Corporation
  • Cardinal Health Inc.
  • Cook Medical LLC
  • Embolx Inc.
  • EndoShape Inc.
  • Guerbet SA
  • Instylla Inc.
  • Johnson & Johnson
  • Kaneka Corporation
  • Medtronic plc
  • Medtronic plc
  • Merit Medical Systems Inc.
  • Penumbra Inc.
  • QT Vascular Ltd.
  • Shape Memory Medical Inc.
  • Sirtex Medical Limited
  • Stryker Corporation
  • Surefire Medical Inc.
  • Terumo Corporation
  • TriSalus Life Sciences Inc.
  • Vascular Solutions Inc.

Table Information

Report AttributeDetails
No. of Pages196
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 5.68 Billion
Forecasted Market Value ( USD ) by 2032 $ 9.67 Billion
Compound Annual Growth Rate9.1%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Embolotherapy Market Forecast to 2033 - Product Image

Embolotherapy Market Forecast to 2033

  • Report
  • 300 Pages
  • Global
From
Embolotherapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Embolotherapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 190 Pages
  • Global
From
Embolotherapy - Global Strategic Business Report - Product Image

Embolotherapy - Global Strategic Business Report

  • Report
  • 282 Pages
  • Global
From
Embolotherapy Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application - Product Image

Embolotherapy Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application

  • Report
  • 109 Pages
  • Global
From
KSA Embolotherapy Market Report: Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025-2030 - Product Image

KSA Embolotherapy Market Report: Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025-2030

  • Report
  • 99 Pages
  • Saudi Arabia
From

About the Embolotherapy Market

Embolotherapy is a minimally invasive medical procedure that involves the use of catheters to deliver therapeutic agents to a specific area of the body. The procedure is used to treat a variety of conditions, including vascular malformations, tumors, and arteriovenous malformations. Catheters are used to deliver embolic agents, such as coils, particles, and glue, to the target area. The catheters are inserted through a small incision in the skin and guided to the target area using imaging techniques such as X-ray, ultrasound, or computed tomography. The embolotherapy market is driven by the increasing prevalence of chronic diseases, the growing demand for minimally invasive procedures, and the availability of advanced catheter technologies. The market is further driven by the increasing adoption of embolotherapy in the treatment of various diseases, such as cancer, cardiovascular diseases, and neurological disorders. Some of the major companies in the embolotherapy market include Boston Scientific Corporation, Cook Medical, Medtronic, Terumo Corporation, Merit Medical Systems, Inc., and BTG plc. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.